Showing results (221-230 of 302) with videos related to

Sort By:
Pageof 31
Magnetic Resonance Imaging|April 11, 2001
Increasing mean airway pressure reduces functional MRI (fMRI) signal in the primary visual cortexI H Lorenz, C Kolbitsch, C Hörmann, et al.
Epilepsy & Behavior : E&B|March 1, 2006
Transient and permanent magnetic resonance imaging abnormalities after complex partial status epilepticusG Bauer, Th Gotwald, J Dobesberger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 24, 2001
The auditory startle reaction in parkinsonian disordersM Kofler, J Müller, G K Wenning, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2003
The natural course of Sneddon syndrome: clinical and magnetic resonance imaging findings in a prospective six year observation studyS M Boesch, A L Plörer, A J Auer, et al.
Clinical Neuropharmacology|August 1, 1990
CQA 206-291: a novel dopamine agonist in the treatment of Parkinson's diseaseO Rascol, N Fabre, H Teräväinen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1996
Iodine-123-iodo-lisuride SPECT in Parkinson's diseaseM Cordes, J Hierholzer, L Schelosky, et al.
European Journal of Neurology|May 17, 2014
Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's diseaseR A Hauser, A H V Schapira, P Barone, et al.
Clinical Neuropharmacology|June 9, 1998
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's diseaseA E Schrag, D J Brooks, E Brunt, et al.
Pageof 31